Cargando…

The association between soluble suppression of tumorigenicity-2 and long-term prognosis in patients with coronary artery disease: A meta-analysis

OBJECTIVE: Findings regarding the prognostic value of soluble suppression of tumorigenecity-2 (sST2) in patients with coronary artery disease (CAD) remain inconsistent. Therefore, we conducted this meta-analysis to investigate the long-term prognostic value of sST2 in patients with CAD. METHODS: A c...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Niannian, Hang, Tao, Gao, Xiang, Yang, Wenxue, Kong, Wenjie, Lou, Qiaozhen, Yang, Jiming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7473587/
https://www.ncbi.nlm.nih.gov/pubmed/32886697
http://dx.doi.org/10.1371/journal.pone.0238775
_version_ 1783579206799589376
author Liu, Niannian
Hang, Tao
Gao, Xiang
Yang, Wenxue
Kong, Wenjie
Lou, Qiaozhen
Yang, Jiming
author_facet Liu, Niannian
Hang, Tao
Gao, Xiang
Yang, Wenxue
Kong, Wenjie
Lou, Qiaozhen
Yang, Jiming
author_sort Liu, Niannian
collection PubMed
description OBJECTIVE: Findings regarding the prognostic value of soluble suppression of tumorigenecity-2 (sST2) in patients with coronary artery disease (CAD) remain inconsistent. Therefore, we conducted this meta-analysis to investigate the long-term prognostic value of sST2 in patients with CAD. METHODS: A comprehensive literature search was conducted across the PubMed, Embase, and Cochrane Library databases up to June 3, 2020. The primary outcome was major adverse cardiac events (MACEs). The secondary outcomes were all-cause mortality, cardiovascular (CV) death, heart failure (HF), and myocardial infarction (MI). Pooled estimations and 95% confidence intervals (CIs) were assessed using a random-effects model. RESULTS: Twenty-two articles that enrolled a total of 17,432 patients with CAD were included in the final analysis. CAD patients in the highest categories of baseline sST2 had a significantly higher risk of MACEs (HR: 1.42, 95% CI: 1.09–1.76), all-cause mortality (HR: 2.00, 95% CI: 1.54–2.46), and CV death (HR: 1.42, 95% CI: 1.15–1.68), HF (HR: 2.41, 95% CI: 1.87–2.94), but not that of MI (HR: 1.15, 95% CI: -0.73–3.04), than those in the lowest categories. These results were consistent when baseline sST2 was presented as continuous values in one unit increments. Moreover, subgroup analysis showed that elevated baseline sST2 levels increased the long-term risk of MACEs in the acute coronary syndrome (ACS) population (HR: 1.74, 95% CI: 1.39–2.09) but only showed a trend toward higher risk of MACEs in the non-ACS population (HR: 1.09, 95% CI: 0.87–1.30). CONCLUSIONS: The findings suggest that a higher concentration of baseline sST2 is associated with a higher risk of MACEs, all-cause mortality, CV death, and HF in patients with CAD. Elevated sST2 levels could significantly predict future MACEs in the ACS population but not in the non-ACS population.
format Online
Article
Text
id pubmed-7473587
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-74735872020-09-14 The association between soluble suppression of tumorigenicity-2 and long-term prognosis in patients with coronary artery disease: A meta-analysis Liu, Niannian Hang, Tao Gao, Xiang Yang, Wenxue Kong, Wenjie Lou, Qiaozhen Yang, Jiming PLoS One Research Article OBJECTIVE: Findings regarding the prognostic value of soluble suppression of tumorigenecity-2 (sST2) in patients with coronary artery disease (CAD) remain inconsistent. Therefore, we conducted this meta-analysis to investigate the long-term prognostic value of sST2 in patients with CAD. METHODS: A comprehensive literature search was conducted across the PubMed, Embase, and Cochrane Library databases up to June 3, 2020. The primary outcome was major adverse cardiac events (MACEs). The secondary outcomes were all-cause mortality, cardiovascular (CV) death, heart failure (HF), and myocardial infarction (MI). Pooled estimations and 95% confidence intervals (CIs) were assessed using a random-effects model. RESULTS: Twenty-two articles that enrolled a total of 17,432 patients with CAD were included in the final analysis. CAD patients in the highest categories of baseline sST2 had a significantly higher risk of MACEs (HR: 1.42, 95% CI: 1.09–1.76), all-cause mortality (HR: 2.00, 95% CI: 1.54–2.46), and CV death (HR: 1.42, 95% CI: 1.15–1.68), HF (HR: 2.41, 95% CI: 1.87–2.94), but not that of MI (HR: 1.15, 95% CI: -0.73–3.04), than those in the lowest categories. These results were consistent when baseline sST2 was presented as continuous values in one unit increments. Moreover, subgroup analysis showed that elevated baseline sST2 levels increased the long-term risk of MACEs in the acute coronary syndrome (ACS) population (HR: 1.74, 95% CI: 1.39–2.09) but only showed a trend toward higher risk of MACEs in the non-ACS population (HR: 1.09, 95% CI: 0.87–1.30). CONCLUSIONS: The findings suggest that a higher concentration of baseline sST2 is associated with a higher risk of MACEs, all-cause mortality, CV death, and HF in patients with CAD. Elevated sST2 levels could significantly predict future MACEs in the ACS population but not in the non-ACS population. Public Library of Science 2020-09-04 /pmc/articles/PMC7473587/ /pubmed/32886697 http://dx.doi.org/10.1371/journal.pone.0238775 Text en © 2020 Liu et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Liu, Niannian
Hang, Tao
Gao, Xiang
Yang, Wenxue
Kong, Wenjie
Lou, Qiaozhen
Yang, Jiming
The association between soluble suppression of tumorigenicity-2 and long-term prognosis in patients with coronary artery disease: A meta-analysis
title The association between soluble suppression of tumorigenicity-2 and long-term prognosis in patients with coronary artery disease: A meta-analysis
title_full The association between soluble suppression of tumorigenicity-2 and long-term prognosis in patients with coronary artery disease: A meta-analysis
title_fullStr The association between soluble suppression of tumorigenicity-2 and long-term prognosis in patients with coronary artery disease: A meta-analysis
title_full_unstemmed The association between soluble suppression of tumorigenicity-2 and long-term prognosis in patients with coronary artery disease: A meta-analysis
title_short The association between soluble suppression of tumorigenicity-2 and long-term prognosis in patients with coronary artery disease: A meta-analysis
title_sort association between soluble suppression of tumorigenicity-2 and long-term prognosis in patients with coronary artery disease: a meta-analysis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7473587/
https://www.ncbi.nlm.nih.gov/pubmed/32886697
http://dx.doi.org/10.1371/journal.pone.0238775
work_keys_str_mv AT liuniannian theassociationbetweensolublesuppressionoftumorigenicity2andlongtermprognosisinpatientswithcoronaryarterydiseaseametaanalysis
AT hangtao theassociationbetweensolublesuppressionoftumorigenicity2andlongtermprognosisinpatientswithcoronaryarterydiseaseametaanalysis
AT gaoxiang theassociationbetweensolublesuppressionoftumorigenicity2andlongtermprognosisinpatientswithcoronaryarterydiseaseametaanalysis
AT yangwenxue theassociationbetweensolublesuppressionoftumorigenicity2andlongtermprognosisinpatientswithcoronaryarterydiseaseametaanalysis
AT kongwenjie theassociationbetweensolublesuppressionoftumorigenicity2andlongtermprognosisinpatientswithcoronaryarterydiseaseametaanalysis
AT louqiaozhen theassociationbetweensolublesuppressionoftumorigenicity2andlongtermprognosisinpatientswithcoronaryarterydiseaseametaanalysis
AT yangjiming theassociationbetweensolublesuppressionoftumorigenicity2andlongtermprognosisinpatientswithcoronaryarterydiseaseametaanalysis
AT liuniannian associationbetweensolublesuppressionoftumorigenicity2andlongtermprognosisinpatientswithcoronaryarterydiseaseametaanalysis
AT hangtao associationbetweensolublesuppressionoftumorigenicity2andlongtermprognosisinpatientswithcoronaryarterydiseaseametaanalysis
AT gaoxiang associationbetweensolublesuppressionoftumorigenicity2andlongtermprognosisinpatientswithcoronaryarterydiseaseametaanalysis
AT yangwenxue associationbetweensolublesuppressionoftumorigenicity2andlongtermprognosisinpatientswithcoronaryarterydiseaseametaanalysis
AT kongwenjie associationbetweensolublesuppressionoftumorigenicity2andlongtermprognosisinpatientswithcoronaryarterydiseaseametaanalysis
AT louqiaozhen associationbetweensolublesuppressionoftumorigenicity2andlongtermprognosisinpatientswithcoronaryarterydiseaseametaanalysis
AT yangjiming associationbetweensolublesuppressionoftumorigenicity2andlongtermprognosisinpatientswithcoronaryarterydiseaseametaanalysis